This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $450,000 in funding to Old Dominion University to investigate the relationship between disturbed sleep and the development of vulnerable atherosclerotic plaques. The primary objectives are to: 1) examine the role of NADPH-dependent oxidative stress in accelerating the formation of vulnerable atherosclerotic plaques in...
This Project Grant award of $696,470.00 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) supports research at the University of Denver to investigate the relationship between prenatal maternal sleep and offspring cardiovascular disease risk. The research aims to: 1) examine how prenatal maternal sleep trajectories predict maternal biological pathways like inflammation and stress, 2) assess how prenatal maternal sleep impacts offspring growth,...
This $684,116 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to examine the mechanisms by which improving sleep regularity affects glycemic control and cardiovascular disease (CVD) risk in adults with type 1 diabetes. The grant will fund a 4-week behavioral sleep stability intervention in 80 adults with type 1 diabetes and irregular sleep...
This federal Project Grant award of $752,991 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program supports a comprehensive study to understand the socioecological factors impacting disparities in early childhood sleep health. The project aims to evaluate the effects of understudied risk factors like racism, housing insecurity, screen media use, and toxic stress on child sleep health, as well as assess how socio-cultural,...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $524,390 to the University of Colorado-Denver to study the relationship between sleep health, circadian timing, and cardiometabolic risk in adolescents with type 1 diabetes. The research aims to utilize a combined sleep health and circadian timing intervention as a mechanistic probe to...
This Project Grant award of $133,410 from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the relationship between sleep quality, sleep apnea, and cardiac aging. The study aims to leverage longitudinal sleep data from the Korean Genome and Epidemiology Study to assess how impaired sleep patterns accelerate cardiovascular disease risk over a 12-year period. The research will focus on...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $165,364 to The Broad Institute, Inc. to conduct research focused on integrating novel contextual and genomic blood pressure measures to enhance cardiovascular disease prediction and management in young adults aged 18-39 years. The key objectives of this 2-year project are to: 1) identify novel ambulatory blood pressure patterns that capture dynamic responses to...
This Project Grant award of $633,671 from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, supports research on the safety of prescription sleep medications in children, adolescents, and young adults with Attention Deficit Hyperactivity Disorder (ADHD). The key objectives are to: 1) Evaluate nationwide patterns of prescription sleep medication use and dose-escalation in youth with ADHD; 2) Determine the extent to which these...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $644,687 to the University of Missouri System to conduct research on a neural circuit in the brain that contributes to hypertension associated with obstructive sleep apnea. The research aims to determine how this "orexin-CRH-NTS" circuit facilitates the peripheral chemoreflex and leads to sympathoexcitation and hypertension,...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under CFDA Program 93.837 - Cardiovascular Diseases Research, provides $691,124 to the Regents of the University of Michigan to study the relationship between circadian disruption and cardiometabolic risk during the transition from adolescence to young adulthood. The research aims to: 1) Test the hypothesis that persistent circadian disruption from adolescence to young adulthood is related to the...
EFFECTS OF EXPERIMENTAL SLEEP RESTRICTION IN OFFSPRING OF HYPERTENSIVE PARENTS - PROJECT SUMMARY HYPERTENSION IS THE CHIEF RISK FACTOR FOR CARDIOVASCULAR (CV) DISEASE AND A MAJOR THREAT TO POPULATION HEALTH. GIVEN THE BURDEN OF HYPERTENSION, IT IS CRITICAL TO IDENTIFY RISK ENHANCERS IN POPULATIONS SUSCEPTIBLE TO CV DISEASE, FOR RISK STRATIFICATION. WHILE FAMILY HISTORY OF HYPERTENSION, ESPECIALLY PARENTAL HYPERTENSION, IS WELL- KNOWN AS A ROBUST PREDICTOR OF HIGH BLOOD PRESSURE (BP) AND CV DISEASE IN THE OFFSPRING, THE ROLE OF CHRONIC SLEEP DEFICIENCY IS BEING INCREASINGLY RECOGNIZED. EVIDENCE FROM EPIDEMIOLOGICAL AND LABORATORY-BASED STUDIES CONVERGES TO INDICATE THAT INSUFFICIENT SLEEP INCREASES BP AND ALTERS CV DISEASE MECHANISMS, THUS PREDISPOSING TO ADVERSE OUTCOMES. WHETHER THE DETRIMENTAL IMPACT OF INSUFFICIENT SLEEP ON CV RISK IS POTENTIATED IN POPULATIONS WITH PREEXISTING VULNERABILITIES, SUCH AS THE OFFSPRING OF HYPERTENSIVE FAMILIES, IS PLAUSIBLE YET UNKNOWN. TO BRIDGE THIS GAP, WE PROPOSE A RANDOMIZED, CONTROLLED, CROSSOVER, 10-DAY INPATIENT STUDY TO INVESTIGATE WHETHER EXPERIMENTAL SLEEP RESTRICTION INCREASES BP AND IMPAIRS CV FUNCTION IN INDIVIDUALS WITH A POSITIVE PARENTAL HISTORY OF HYPERTENSION (+PHH), AND WHETHER THE HYPOTHESIZED ADVERSE IMPACT OF SHORTENED SLEEP IS GREATER IN THIS GROUP COMPARED TO INDIVIDUALS WITH A NEGATIVE PHH (PHH). WE PROPOSE THE FOLLOWING SPECIFIC AIMS COMPARING SLEEP RESTRICTION TO NORMAL SLEEP IN THE OFFSPRING OF HYPERTENSIVE PARENTS RELATIVE TO THE OFFSPRING OF NORMOTENSIVE PARENTS. AIM 1. TO COMPARE THE EFFECTS OF SLEEP RESTRICTION ON AMBULATORY BP IN INDIVIDUALS WITH A +PHH COMPARED TO THOSE WITH A PHH. AIM 2. TO DETERMINE THE IMPACT OF SLEEP RESTRICTION ON NEURAL CIRCULATORY CONTROL AND VASCULAR FUNCTION IN INDIVIDUALS WITH A +PHH COMPARED TO THOSE WITH A PHH. AIM 3. TO EXPLORE EPIGENETIC AND TRANSCRIPTOMIC MODIFICATIONS IN RESPONSE TO SLEEP RESTRICTION IN INDIVIDUALS WITH A +PHH COMPARED TO THOSE WITH A PHH. THIS PROPOSAL BUILDS UPON IMPORTANT STRENGTHS, INCLUDING AN INTERDISCIPLINARY TEAM OF INVESTIGATORS WITH UNIQUE EXPERIENCE AND EXPERTISE; SUPPORTING PRELIMINARY DATA; A ROBUST STUDY DESIGN WHICH WILL ENSURE RIGOROUS AND UNBIASED RESEARCH; AND INTEGRATION OF PHYSIOLOGICAL, BEHAVIORAL, AND OMICS VARIABLES IN A TRANSLATIONAL FRAMEWORK. THIS MECHANISTIC STUDY WILL INFORM ON THE ROLE OF SLEEP DEFICIENCY AS A CV RISK ENHANCER IN INDIVIDUALS WITH FAMILIAL PREDISPOSITION TO HYPERTENSION, AND GUIDE FUTURE PREVENTATIVE STRATEGIES TARGETING SLEEP TO AMELIORATE CV RISK IN VULNERABLE POPULATIONS.